Washington D.C., Mar 13, 2023 / 14:50 pm
The first hearing in what could be the most consequential abortion case since the overturning of Roe v. Wade is set for this Wednesday, March 15.
The Alliance for Hippocratic Medicine (AHM), along with several other medical organizations and doctors, is suing the Federal Drug Administration for its approval and expansion of the abortion drug mifepristone.
On Jan. 3, the FDA changed its policy to allow pharmacies, such as CVS and Walgreens, to sell mifepristone. Previously, the FDA only allowed certified doctors, clinics, and some mail-order pharmacies to dispense the drug. After the FDA’s policy change, any patient with a prescription can obtain mifepristone from her local retail pharmacy.
Represented by the Alliance Defending Freedom (ADF), AHM is alleging that the FDA has been recklessly endangering women and young girls for decades by ignoring its own research and testing standards and continuing to expand its mifepristone approval.